| Description | Levoprotiline an antidepressant compound that is the R-(-) enantiomer of Oxaprotiline, acts comparably to Oxaprotiline and has a shorter latency to onset of action. It is the successor to the second-generation antidepressant maprotiline. |
| Synonyms | Levoprotilinum |
| molecular weight | 293.4 |
| Molecular formula | C20H23NO |
| CAS | 76496-68-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Kaiser G, Ackermann R, Dieterle W, Reimann IW, Bieck PR. Pharmacokinetics of the antidepressant levoprotiline after intravenous and peroral administration in healthy volunteers. Biopharm Drug Dispos. 1992 Mar;13(2):83-93. PubMed PMID: 1550911. 2. Náhunek K, Svestka J, Cesková E, Rysánek R, Obrovská V, Misurec J, Wendt G. Position of levoprotiline in the treatment of acute endogenous depression. Act Nerv Super (Praha). 1989 Dec;31(4):280-1. PubMed PMID: 2638110. 3. Ackermann R, Kaiser G, Schueller F, Dieterle W. Determination of the antidepressant levoprotiline and its N-desmethyl metabolite in biological fluids by gas chromatography/mass spectrometry. Biol Mass Spectrom. 1991 Nov;20(11):709-16. PubMed PMID: 1799582. 4. Höschl C, Filip V, Bornová L, David I, Karen P, Seifertová D. [Results of a clinical trial of levoprotiline]. Cesk Psychiatr. 1992 Jun;88(2):97-105. Czech. PubMed PMID: 1505054. |